Croda International Plc (Croda) announced that it has signed two new partnership agreements that will help the Pharmaceutical Industry move towards a more sustainable supply chain for vaccine adjuvants. The first partnership is an exclusive license agreement with Amyris, a leading synthetic biology company, for the supply of biotechnology-derived, pharmaceutical grade squalene used in adjuvants […]

The post Croda announces two new partnerships to drive sustainable delivery systems for the pharmaceutical industry first appeared on World Pharma Today.